FDA.reportPublic FDA data

MG217 Psoriasis Therapeutic Conditioner

Manufacturer
Wisconsin Pharmacal Company
Effective date
2026-03-20
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:51:00

Label at a glance#

ProductMG217 Psoriasis Therapeutic Conditioner
Active ingredientSALICYLIC ACID
Label structure11 sections

Indications and uses

For the temporary relief of these symptoms associate with psoriasis, seborrheic dermatitis or dandruff itching scaling flaking, reness irritaion of the scalp Helps prevent recurrence.

Dosage and administration

wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly. for best results, use at least twice a week or as directed by a physician.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 3%

Purpose

OTC - PURPOSE SECTION

Psoriasis, Seborrheic Dermatitis, Dandruff Treatment

Uses

INDICATIONS & USAGE SECTION

For the temporary relief of these symptoms associate with psoriasis, seborrheic dermatitis or dandruff

  • itching
  • scaling
  • flaking,
  • reness
  • irritaion of the scalp

Helps prevent recurrence.

Warnings

WARNINGS SECTION

For external use only.

Ask a doctor before use

OTC - ASK DOCTOR SECTION

  • if condition covers larger area of body, consult your doctor before using this product.

When using this product

OTC - WHEN USING SECTION

  • avoid contact wtih the eyes. If contact occurs, rinse thoroughly with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition worsens or does not improve after regular use of this product as directed, consult a doctor.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center Immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly.
  • for best results, use at least twice a week or as directed by a physician.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Purified water, Sodium laureth sulfate, Cocamidopropyl betaine, Lauryl glucoside, Sodium citrate, Coco-glucoside, Glyceryl oleate, Propanediol, Glycerin, Polyquaterinum-44, Sodium benzoate, Panthenol, Calendula officinalis flower extract, Chamomilla recutita (matricaria) flower extract, Propylene glycol, Citric acid, Chlorhexidine gluconate, Disodium EDTA

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Salicylic Acid Multi-symptom Therapeutic Shampoo and ConditionerSalicylic Acid Multi-symptom Therapeutic Shampoo and Conditioner

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1744041MG217 Psoriasis Salicylic Acid 3 % Medicated ConditionerPSN2
205023salicylic acid 3 % Medicated ShampooPSN2
1744041salicylic acid 30 MG/ML Medicated Shampoo [MG217 Psoriasis Salicylic Acid]SBD2
205023salicylic acid 30 MG/ML Medicated ShampooSCD2
1744041MG217 Psoriasis Salicylic Acid 30 MG/ML Medicated ShampooSY2
205023salicylic acid 3 % Medicated ShampooSY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717
bb6d6c68-649d-4e6d-a1f6-603d969c8f68Product name120160303
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68093-7242-2MG217 Psoriasis Therapeutic Conditioner283 g in 1 TUBESHAMPOO2832

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68093-724268093-7242-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Name, UNII, Kind table
NameUNIIKind
POLYQUATERNIUM-44 (200000 MW)TTD9VOM83OIACT
PANTHENOLWV9CM0O67ZIACT
CALENDULA OFFICINALIS FLOWERP0M7O4Y7YDIACT
MATRICARIA CHAMOMILLA FLOWERING TOP OILSA8AR2W4ERIACT
PROPYLENE GLYCOL6DC9Q167V3IACT
EDETATE DISODIUM7FLD91C86KIACT
GLYCERYL OLEATE4PC054V79PIACT
SALICYLIC ACIDO414PZ4LPZACTIB
LAURYL GLUCOSIDE76LN7P7UCUIACT
COCO GLUCOSIDEICS790225BIACT
PROPANEDIOL5965N8W85TIACT
COCAMIDOPROPYL BETAINE5OCF3O11KXIACT
SODIUM BENZOATEOJ245FE5EUIACT
CITRIC ACID MONOHYDRATE2968PHW8QPIACT
CHLORHEXIDINE GLUCONATEMOR84MUD8EIACT
WATER059QF0KO0RIACT
SODIUM LAURETH SULFATEBPV390UAP0IACT
SODIUM CITRATE1Q73Q2JULRIACT
GLYCERINPDC6A3C0OXIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MG217 Psoriasis Therapeutic ConditionerSALICYLIC ACIDWisconsin Pharmacal Company246f239f-16fb-24b2-e054-00144ff8d46c2026-03-20WarningsExact identifier
ndc (package): 68093-7242-2
ndc (product): 68093-7242
ndc11 (package): 68093724202
spl id: 4d79f32e-ac63-e886-e063-6394a90af2c0
spl set id: 246f239f-16fb-24b2-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.